News & Events category:
Wythenshawe, Trafford, Withington and Altrincham

A new once-daily cystic fibrosis treatment trialled in Manchester has been approved for NHS use.

Manchester’s Inward Investment Agency, MIDAS, has launched a new life sciences prospectus showcasing the city-region's position as one of the UK's most dynamic health innovation ecosystems.

Congratulations to Manchester University NHS Foundation Trust researchers who were recognised at this year’s Making a Difference Awards 2025, hosted by The University of Manchester.

Congratulations to Oluwakemi Normansell on her successful completion of the Windrush Nurses and Midwives Leadership Programme.

A team of international clinical experts, including Manchester researchers, have published the new global guideline for the diagnosis and treatment of Candida infections.

The second phase of a groundbreaking breast cancer study created at the request of Girls Aloud singer Sarah Harding, will begin later this year in her name.

New research from MFT has shown at a DNA-based test is accurate for diagnosing fungal pneumonia caused by Pneumocystis jirovecii in people with weakened immune systems. 

New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.